Shefali Godara, MD
Pulmonary Disease Physician · Reno, NV
Shefali Godara, MD is a pulmonary disease physician with a practice address in Reno, Nevada, and NPI 1265886592, issued on Apr 23, 2016. Check the license (Nevada 21807, as entered in NPPES) on the Nevada State Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Shefali Godara
- Credential
- MD
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- 21807 NV
Self-reported in NPPES; status is on the state search - Practice location
- 645 N Arlington Ave Ste 525, Reno, NV 89503
- Phone
- (775) 770-7527
- Enumerated
- Apr 23, 2016
- Record last updated
- Dec 28, 2022
- Medicare enrollment
- Enrolled (PECOS I20240311000866); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest pulmonary disease physician records → All 90 in Nevada → Look up another NPI →
Also registered at 645 N Arlington Ave Ste 525
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Christopher Abellana-PlaterosPrimary Care Nurse Practitioner1992634877
- David Surujpaul, MDFamily Medicine Physician1457039778
Verify Shefali Godara in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNevada State Board of Medical Examiners
Search for license 21807Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
79% fewer Medicare Part D claims than the average pulmonary disease physician in 2024
303 Medicare Part D claims for 83 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 74% of claims.
Most prescribed
- Trelegy Ellipta84 claims
- Albuterol Sulfate Hfa37 claims
- Breztri Aerosphere20 claims
- Montelukast Sodium18 claims
- Anoro Ellipta16 claims
- Fluticasone Propionate16 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 91.6 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Bills Medicare through one group practice
- University Physician GroupDetroit, MI
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Shefali Godara among 90 pulmonary disease physician records in Nevada
Shefali Godara, MD is one of 90 pulmonary disease physician records with a practice address in Nevada. 92% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2016, is newer than 84% of them.
- NPI issued2016 · 84% of these records are older, 11% newer
- In a Medicare fileYes · 92% of these records are
- In the CMS Doctors and Clinicians fileYes · 77% of these records are
- Graduated2014 · median 2007 among the 69 with a school on file
- Record last updated2022 · 30% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a Nevada practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pulmonary Disease Physician providers in Nevada
There are 90 pulmonary disease physician records in Nevada.
All 90 in Nevada → Every provider in Reno → Pulmonary Disease Physician nationwide →
The 8 pulmonary disease physician records with the nearest ZIP codes
- Shibu Skaria, M.D.Reno, NV 895031821170093
- Keith AlbrektsonReno, NV 895021144755992
- Stephen Baez, MDReno, NV 895021851376123
- Julia Christopher, D.O.Reno, NV 895021447601281
- Aaron Dobie, MDReno, NV 895021356873020
- William Graham, M.D.Reno, NV 895021952668105
- Hafiz Mahboob, MDReno, NV 895021477947612
- Gregory Matwiyoff, M.D.Reno, NV 895021932248093
Common questions
What is Shefali Godara, MD's NPI number?
Shefali Godara, MD's National Provider Identifier (NPI) is 1265886592, issued on Apr 23, 2016. An NPI identifies a provider in billing; it is not a license.
Where is Shefali Godara, MD located?
The NPPES record lists a practice address at 645 N Arlington Ave Ste 525, Reno, NV, 89503. Phone: (775) 770-7527. Providers update this record themselves, so call before visiting.
How can I verify Shefali Godara, MD's license?
NPPES lists Nevada license number 21807, as entered by the provider. Search the Nevada State Board of Medical Examiners at https://medboard.nv.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Shefali Godara, MD prescribe under Medicare Part D?
In 2024, Shefali Godara, MD had 303 Medicare Part D claims for 83 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
What is Shefali Godara, MD's MIPS final score?
The 2023 MIPS final score is 91.6 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.